» Articles » PMID: 8394240

Signs and Symptoms in Common Colds

Overview
Date 1993 Aug 1
PMID 8394240
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The patterns of disease caused by five common viruses which infect the respiratory tract are described. The viruses were strains of rhinovirus types 2, 9, and 14, a strain of coronavirus type 229E and of respiratory syncytial virus. Volunteers were given nasal drops containing a low infectious dose of one of the viruses, quarantined from 2 days before to 5 days after inoculation, and examined daily by a clinician using a standard checklist of respiratory signs and symptoms. Only subjects who developed clinical illness accompanied by viral shedding and/or specific antibody production were analysed [n = 116]. The results confirm indication from earlier studies that the main difference between colds induced by different viruses is in duration of the incubation period. Patterns of symptom development were not substantially different with different viruses. Analyses of signs and symptoms in different categories, e.g. nasal symptoms v. coughing, justify treatment with different drugs either successively or simultaneously.

Citing Articles

Optimism as a key factor in coping with the common cold.

Puig-Perez S, Kozusznik M, Pulopulos M Brain Behav Immun Health. 2024; 37:100748.

PMID: 38524895 PMC: 10957377. DOI: 10.1016/j.bbih.2024.100748.


Influenza-like illness symptoms due to endemic human coronavirus reinfections are not influenced by the length of the interval separating reinfections.

Sechan F, Edridge A, van Rijswijk J, Jebbink M, Deijs M, Bakker M Microbiol Spectr. 2024; 12(3):e0391223.

PMID: 38329364 PMC: 10913438. DOI: 10.1128/spectrum.03912-23.


Association between the Seroprevalence of Antibodies against Seasonal Alphacoronaviruses and SARS-CoV-2 Humoral Immune Response, COVID-19 Severity, and Influenza Vaccination.

Brydak L, Sikora D, Poniedzialek B, Hallmann E, Szymanski K, Kondratiuk K J Clin Med. 2023; 12(5).

PMID: 36902520 PMC: 10003754. DOI: 10.3390/jcm12051733.


Controlled Human Infection Challenge Studies with RSV.

Dayananda P, Chiu C, Openshaw P Curr Top Microbiol Immunol. 2022; 445:41-68.

PMID: 35704096 DOI: 10.1007/82_2022_257.


Human Challenge Studies with Coronaviruses Old and New.

McKendry R, Lemm N, Papargyris L, Chiu C Curr Top Microbiol Immunol. 2022; 445:69-108.

PMID: 35181805 DOI: 10.1007/82_2021_247.


References
1.
Taylor-Robinson D, Bynoe M . PARA-INFLUENZA 2 VIRUS INFECTIONS IN ADULT VOLUNTEERS. J Hyg (Lond). 1963; 61:407-17. PMC: 2134565. DOI: 10.1017/s0022172400021021. View

2.
Bradburne A, Bynoe M, Tyrrell D . Effects of a "new" human respiratory virus in volunteers. Br Med J. 1967; 3(5568):767-9. PMC: 1843247. DOI: 10.1136/bmj.3.5568.767. View

3.
BUCKLAND F, Bynoe M, Philipson L, Tyrrell D . Experimental infection of human volunteers with the U-virus-a strain of ECHO virus type 11. J Hyg (Lond). 1959; 57:274-84. PMC: 2218107. DOI: 10.1017/s0022172400020131. View

4.
Tyrrell D, Bynoe M, Petersen K, Sutton R, Pereira M . Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1). Br Med J. 1959; 2(5157):909-11. PMC: 1990654. DOI: 10.1136/bmj.2.5157.909. View

5.
Callow K, Tyrrell D, Shaw R, Fitzharris P, Wardlaw A, Kay A . Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteers. Clin Allergy. 1988; 18(2):119-29. PMC: 7194196. DOI: 10.1111/j.1365-2222.1988.tb02851.x. View